Zobrazeno 1 - 10
of 71
pro vyhledávání: '"Xinxing Lai"'
Autor:
Cuilin Que, Yupeng Wei, Guanxiang Yin, Congren Zhou, Zhenhong Liu, Xinxing Lai, Mingzhen Qin, Xuejiao Xiong, Xiangyi Zheng, Xinglu Dong, Ying Gao
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
BackgroundStroke is a serious health issue that can result in death or disability, leading to a significant economic strain on society and families. A growing number of studies have shown that the Naoshuantong capsule (NSTC) is beneficial as a treatm
Externí odkaz:
https://doaj.org/article/2c5690782712457fac4582f0e062c271
Autor:
Xinxing Lai1,2, Zhenghao Fang3,4, Zhenyu Dong5, Shengxian Wu1, Xiaohua Zhou3,4 azhou@math.pku.edu.cn, Ying Gao1,2 gaoying97@163.com
Publikováno v:
Clinical & Experimental Hypertension. Dec2023, Vol. 45 Issue 1, p1-7. 7p.
Publikováno v:
Frontiers in Neurology, Vol 14 (2023)
BackgroundMoyamoya disease (MMD) is a leading cause of stroke in children and young adults, whereas no specific drugs are available. Antiplatelet therapy (APT) has been considered a promising treatment option, but its effectiveness remains controvers
Externí odkaz:
https://doaj.org/article/b43096ecfa344d9d8e6981403278877b
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Deciphering the biological basis of traditional Chinese medicine (TCM) syndromes in complex diseases is challenging. Rapid advances in multi-omics approaches provide new opportunities to unveil the biological basis of TCM syndromes. We in
Externí odkaz:
https://doaj.org/article/5fd697cacaa94bfab5dc30fae713f748
Autor:
Dandan Zhang, Tingting Li, Anxin Wang, Luda Feng, Xinxing Lai, Kegang Cao, Li Zhou, Baolin Yang, Fangyuan Cui, Qingbin Li, Jinjuan Dou, Baoyun Qi, Chi Zhang, Ying Gao
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Due to limited time windows and technical requirements, only a small percentage of patients can receive reperfusion therapy for acute ischemic stroke (AIS). Previous studies have shown that LongShengZhi (LSZ) capsule can improve neurologi
Externí odkaz:
https://doaj.org/article/8ccd5be92b5545ed8a57cc05cd49a90c
Autor:
Mingzhen Qin, Luda Feng, Chinyu Yang, Dawei Wei, Tingting Li, Ping Jiang, Jinzhi Guan, Xinyue Zhang, Xinyi Shi, Ning Liang, Xinxing Lai, Li Zhou, Chi Zhang, Ying Gao
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Edaravone alleviates neurological deficits among patients with intracerebral hemorrhage; however, its effects on mortality and long-term functional outcomes remain unknown.Objective: To assess clinical outcomes associated with edaravone i
Externí odkaz:
https://doaj.org/article/71ba2c8aa8224817ba57a55493ec0432
Autor:
Tingting Li, Xuebin Zhang, Ping Jiang, Dandan Zhang, Luda Feng, Xinxing Lai, Mingzhen Qin, Yufei Wei, Chi Zhang, Ying Gao
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: Acute ischemic stroke (AIS) is a common cause of death and long-term disability worldwide. Recent trials of platelet-activating factor receptor antagonists (PAFRA) appeared to indicate that they could play a neuroprotective role in the tr
Externí odkaz:
https://doaj.org/article/276fa0459be94be0a449f7e51c6bff80
Autor:
Yuanyuan Chen, Ziyu Tian, Shuyan Wang, Hongmei Liu, Yanfang Liu, Wei Peng, Xinxing Lai, Dahe Qi, Lingbo Kong, Ying Gao
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Background: As the only traditional Chinese medicine injection approved by the China Food and Drug Administration for use as stroke first aid in ambulances, Xingnaojing Injection (XNJI) has been widely used in cases of both acute ischemic stroke (IS)
Externí odkaz:
https://doaj.org/article/5c9ce96137e34b9780f585e46bc23c96
Publikováno v:
Frontiers in Neurology, Vol 13 (2022)
Cerebral small vessel disease (CSVD) is the most common chronic vascular disease involving the whole brain. Great progress has been made in clinical imaging, pathological mechanism, and treatment of CSVD, but many problems remain. Clarifying the curr
Externí odkaz:
https://doaj.org/article/3b9246432ecd4e26a2d00400a75eb9d9
Autor:
Luda Feng, Lingbo Kong, Xinglu Dong, Xinxing Lai, Dandan Zhang, Beida Ren, Shen Liu, Xiaolong Xie, Chuanpeng Li, Yuebo Song, Yawei Du, Kegang Cao, Chi Zhang, Ying Gao, On Behalf of the CASES-TCM Protocol Steering Group
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2021)
Background: Given the complexity of stroke treatment and the current widespread use of traditional Chinese medicine (TCM) in the absence of robust, large, long-term effectiveness and safety studies, and the lack of nationwide epidemiology and clinica
Externí odkaz:
https://doaj.org/article/339429f60e9c426a9d3a13814bd09284